Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening.

Saved in:
Bibliographic Details
Title: Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening.
Authors: Asero C; Division of Medicine and Hepatology, University Hospital of Messina, Messina, Italy.; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., Oliveri C; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; Geriatric Unit, University Hospital of Messina, Messina, Italy., Franzè MS; Division of Medicine and Hepatology, University Hospital of Messina, Messina, Italy.; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy., Basile G; Geriatric Unit, University Hospital of Messina, Messina, Italy.; Department of Biomedical and Dental Science and Morphofunctional Imaging, University of Messina, Messina, Italy., Catalano A; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; Geriatric Unit, University Hospital of Messina, Messina, Italy., Cacciola I; Division of Medicine and Hepatology, University Hospital of Messina, Messina, Italy.; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 Aug 14; Vol. 17, pp. 1901793. Date of Electronic Publication: 2026 Aug 14 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first